IBDEI14Z ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,19335,2)
 ;;=^119732
 ;;^UTILITY(U,$J,358.3,19336,0)
 ;;=B35.5^^84^918^282
 ;;^UTILITY(U,$J,358.3,19336,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19336,1,3,0)
 ;;=3^Tinea Imbricata
 ;;^UTILITY(U,$J,358.3,19336,1,4,0)
 ;;=4^B35.5
 ;;^UTILITY(U,$J,358.3,19336,2)
 ;;=^119725
 ;;^UTILITY(U,$J,358.3,19337,0)
 ;;=B35.4^^84^918^280
 ;;^UTILITY(U,$J,358.3,19337,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19337,1,3,0)
 ;;=3^Tinea Corporis
 ;;^UTILITY(U,$J,358.3,19337,1,4,0)
 ;;=4^B35.4
 ;;^UTILITY(U,$J,358.3,19337,2)
 ;;=^119704
 ;;^UTILITY(U,$J,358.3,19338,0)
 ;;=B35.8^^84^918^137
 ;;^UTILITY(U,$J,358.3,19338,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19338,1,3,0)
 ;;=3^Dermatophytoses,Other
 ;;^UTILITY(U,$J,358.3,19338,1,4,0)
 ;;=4^B35.8
 ;;^UTILITY(U,$J,358.3,19338,2)
 ;;=^5000606
 ;;^UTILITY(U,$J,358.3,19339,0)
 ;;=B36.9^^84^918^272
 ;;^UTILITY(U,$J,358.3,19339,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19339,1,3,0)
 ;;=3^Superficial Mycosis,Unspec
 ;;^UTILITY(U,$J,358.3,19339,1,4,0)
 ;;=4^B36.9
 ;;^UTILITY(U,$J,358.3,19339,2)
 ;;=^5000611
 ;;^UTILITY(U,$J,358.3,19340,0)
 ;;=D69.0^^84^918^32
 ;;^UTILITY(U,$J,358.3,19340,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19340,1,3,0)
 ;;=3^Allergic Purpura
 ;;^UTILITY(U,$J,358.3,19340,1,4,0)
 ;;=4^D69.0
 ;;^UTILITY(U,$J,358.3,19340,2)
 ;;=^5002365
 ;;^UTILITY(U,$J,358.3,19341,0)
 ;;=B00.9^^84^918^158
 ;;^UTILITY(U,$J,358.3,19341,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19341,1,3,0)
 ;;=3^Herpesviral Infection,Unspec
 ;;^UTILITY(U,$J,358.3,19341,1,4,0)
 ;;=4^B00.9
 ;;^UTILITY(U,$J,358.3,19341,2)
 ;;=^5000480
 ;;^UTILITY(U,$J,358.3,19342,0)
 ;;=B02.9^^84^918^291
 ;;^UTILITY(U,$J,358.3,19342,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19342,1,3,0)
 ;;=3^Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,19342,1,4,0)
 ;;=4^B02.9
 ;;^UTILITY(U,$J,358.3,19342,2)
 ;;=^5000501
 ;;^UTILITY(U,$J,358.3,19343,0)
 ;;=D17.9^^84^918^89
 ;;^UTILITY(U,$J,358.3,19343,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19343,1,3,0)
 ;;=3^Benign Lipomatous Neop,Unspec
 ;;^UTILITY(U,$J,358.3,19343,1,4,0)
 ;;=4^D17.9
 ;;^UTILITY(U,$J,358.3,19343,2)
 ;;=^5002020
 ;;^UTILITY(U,$J,358.3,19344,0)
 ;;=E08.621^^84^918^134
 ;;^UTILITY(U,$J,358.3,19344,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19344,1,3,0)
 ;;=3^DM d/t Underlying Condition w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,19344,1,4,0)
 ;;=4^E08.621
 ;;^UTILITY(U,$J,358.3,19344,2)
 ;;=^5002534
 ;;^UTILITY(U,$J,358.3,19345,0)
 ;;=E09.621^^84^918^133
 ;;^UTILITY(U,$J,358.3,19345,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19345,1,3,0)
 ;;=3^DM d/t Drug/Chemical w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,19345,1,4,0)
 ;;=4^E09.621
 ;;^UTILITY(U,$J,358.3,19345,2)
 ;;=^5002576
 ;;^UTILITY(U,$J,358.3,19346,0)
 ;;=H05.011^^84^918^110
 ;;^UTILITY(U,$J,358.3,19346,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19346,1,3,0)
 ;;=3^Cellulitis of Right Orbit
 ;;^UTILITY(U,$J,358.3,19346,1,4,0)
 ;;=4^H05.011
 ;;^UTILITY(U,$J,358.3,19346,2)
 ;;=^5004560
 ;;^UTILITY(U,$J,358.3,19347,0)
 ;;=H05.012^^84^918^103
 ;;^UTILITY(U,$J,358.3,19347,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19347,1,3,0)
 ;;=3^Cellulitis of Left Orbit
 ;;^UTILITY(U,$J,358.3,19347,1,4,0)
 ;;=4^H05.012
 ;;^UTILITY(U,$J,358.3,19347,2)
 ;;=^5004561
 ;;^UTILITY(U,$J,358.3,19348,0)
 ;;=H05.013^^84^918^97
 ;;^UTILITY(U,$J,358.3,19348,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,19348,1,3,0)
 ;;=3^Cellulitis of Bilateral Orbits
 ;;^UTILITY(U,$J,358.3,19348,1,4,0)
 ;;=4^H05.013
 ;;^UTILITY(U,$J,358.3,19348,2)
 ;;=^5004562
 ;;^UTILITY(U,$J,358.3,19349,0)
 ;;=I70.331^^84^918^50
